Jim Gilligan, Interim CEO & Chief Scientific Officer of Tryp Therapeutics
6/16/2022
Copy link to Clipboard

Jim Gilligan, Interim CEO & Chief Scientific Officer of Tryp Therapeutics

This week on The Green Rush, Anne Donohoe and Sirita Wright are back with a new episode with guest Jim Gilligan, Interim Chief Executive Officer & Chief Scientific Officer of Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnolog...

More details
Bullhorn
(519)

Get Started

Download the App